Dean Hematology and Oncology Clinic

Summary

Dean Hematology and Oncology Clinic is a medical facility located in Madison, Wisconsin. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer, Multiple Myeloma and other specialties. Dean Hematology and Oncology Clinic is involved with conducting 56 clinical trials across 91 conditions. There are 3 research doctors associated with this hospital, such as Ryan F. Porter, Lisa M. Lepeak, and James M. Heun.

Top PIs

Clinical Trials running at Dean Hematology and Oncology Clinic

Multiple Myeloma

Bladder Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Lymphoma

Ovarian Cancer

Esophageal cancer

Pancreatic Cancer

Cancer

Combination Therapy

for Multiple Myeloma

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.

Recruiting

2 awards

Phase 3

32 criteria

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria